BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34310727)

  • 1. Histone-deacetylase 8 drives the immune response and the growth of glioma.
    Mormino A; Cocozza G; Fontemaggi G; Valente S; Esposito V; Santoro A; Bernardini G; Santoni A; Fazi F; Mai A; Limatola C; Garofalo S
    Glia; 2021 Nov; 69(11):2682-2698. PubMed ID: 34310727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.
    Hu E; Chen Z; Fredrickson T; Zhu Y; Kirkpatrick R; Zhang GF; Johanson K; Sung CM; Liu R; Winkler J
    J Biol Chem; 2000 May; 275(20):15254-64. PubMed ID: 10748112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.
    Ha SD; Reid C; Meshkibaf S; Kim SO
    J Biol Chem; 2016 Apr; 291(16):8745-55. PubMed ID: 26912657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.
    Emmons MF; Faião-Flores F; Sharma R; Thapa R; Messina JL; Becker JC; Schadendorf D; Seto E; Sondak VK; Koomen JM; Chen YA; Lau EK; Wan L; Licht JD; Smalley KSM
    Cancer Res; 2019 Jun; 79(11):2947-2961. PubMed ID: 30987999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
    Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
    Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
    Amin SA; Khatun S; Gayen S; Das S; Jha T
    Eur J Med Chem; 2023 Oct; 258():115594. PubMed ID: 37429084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
    Vanaja GR; Ramulu HG; Kalle AM
    Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
    Findeisen HM; Gizard F; Zhao Y; Qing H; Heywood EB; Jones KL; Cohn D; Bruemmer D
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):851-60. PubMed ID: 21233448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function.
    Watters JM; Wright G; Smith MA; Shah B; Wright KL
    Biochem Biophys Res Commun; 2021 Jan; 534():773-779. PubMed ID: 33190829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages.
    Ha SD; Han CY; Reid C; Kim SO
    J Immunol; 2014 Aug; 193(3):1333-43. PubMed ID: 24973453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.
    Suzuki T; Muto N; Bando M; Itoh Y; Masaki A; Ri M; Ota Y; Nakagawa H; Iida S; Shirahige K; Miyata N
    ChemMedChem; 2014 Mar; 9(3):657-64. PubMed ID: 24403121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.
    Lehmann M; Hoffmann MJ; Koch A; Ulrich SM; Schulz WA; Niegisch G
    J Exp Clin Cancer Res; 2014 Jul; 33(1):59. PubMed ID: 25011684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
    Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
    Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
    Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
    Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
    Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma.
    Yang W; Feng Y; Zhou J; Cheung OK; Cao J; Wang J; Tang W; Tu Y; Xu L; Wu F; Tan Z; Sun H; Tian Y; Wong J; Lai PB; Chan SL; Chan AW; Tan PB; Chen Z; Sung JJ; Yip KY; To KF; Cheng AS
    Sci Transl Med; 2021 Apr; 13(588):. PubMed ID: 33827976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.
    Fass DM; Reis SA; Ghosh B; Hennig KM; Joseph NF; Zhao WN; Nieland TJ; Guan JS; Kuhnle CE; Tang W; Barker DD; Mazitschek R; Schreiber SL; Tsai LH; Haggarty SJ
    Neuropharmacology; 2013 Jan; 64():81-96. PubMed ID: 22771460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of non-substrate, environmentally sensitive turn-on fluorescent probes for imaging HDAC8 in tumor cells and tissue slices.
    Huang C; Shu Y; Zhu Y; Liu H; Wang X; Wen H; Liu J; Li W
    Bioorg Med Chem; 2022 Aug; 68():116821. PubMed ID: 35661851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.